(Z)-N-(3-(Diethylamino)propyl)-5-((5-fluoro-2-oxoindolin-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3-carboxamide

ID: ALA4788980

PubChem CID: 71157876

Max Phase: Preclinical

Molecular Formula: C23H29FN4O2

Molecular Weight: 412.51

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CCN(CC)CCCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C

Standard InChI:  InChI=1S/C23H29FN4O2/c1-5-28(6-2)11-7-10-25-23(30)21-14(3)20(26-15(21)4)13-18-17-12-16(24)8-9-19(17)27-22(18)29/h8-9,12-13,26H,5-7,10-11H2,1-4H3,(H,25,30)(H,27,29)/b18-13-

Standard InChI Key:  MLSDVCJXCYFKAJ-AQTBWJFISA-N

Molfile:  

 
     RDKit          2D

 30 32  0  0  0  0  0  0  0  0999 V2000
    1.0736  -17.0168    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0725  -17.8442    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7872  -18.2571    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7854  -16.6040    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5008  -17.0132    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5011  -17.8442    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2916  -18.1008    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.7799  -17.4283    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2912  -16.7562    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3590  -16.6044    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    3.5458  -15.9714    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6049  -17.4280    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.3533  -15.8012    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9050  -16.4126    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.6569  -16.0769    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5701  -15.2581    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7644  -15.0878    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4282  -14.3344    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1826  -14.7053    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9675  -14.9594    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.0102  -13.8986    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.3718  -16.4887    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5800  -14.4068    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.3650  -14.6609    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.9775  -14.1083    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.7623  -14.3624    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.9347  -15.1692    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.3749  -13.8097    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.7196  -15.4233    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.1597  -14.0639    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  6  2  0
  5  4  2  0
  4  1  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9  5  1  0
  1 10  1  0
  9 11  2  0
 11 13  1  0
  8 12  2  0
 13 14  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 13  2  0
 17 18  1  0
 16 19  1  0
 19 20  1  0
 19 21  2  0
 15 22  1  0
 20 23  1  0
 23 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
 26 28  1  0
 27 29  1  0
 28 30  1  0
M  END

Associated Targets(Human)

PRKAA1 Tclin AMP-activated protein kinase, alpha-1 subunit (2493 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PRKAA2 Tchem AMP-activated protein kinase, alpha-2 subunit (1328 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KDR Tclin Vascular endothelial growth factor receptor 2 (20924 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
K562 (73714 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 412.51Molecular Weight (Monoisotopic): 412.2275AlogP: 3.73#Rotatable Bonds: 8
Polar Surface Area: 77.23Molecular Species: BASEHBA: 3HBD: 3
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: 11.47CX Basic pKa: 9.83CX LogP: 2.84CX LogD: 0.58
Aromatic Rings: 2Heavy Atoms: 30QED Weighted: 0.46Np Likeness Score: -1.16

References

1. Matheson CJ,Casalvieri KA,Backos DS,Minhajuddin M,Jordan CT,Reigan P.  (2020)  Substituted oxindol-3-ylidenes as AMP-activated protein kinase (AMPK) inhibitors.,  197  [PMID:32334266] [10.1016/j.ejmech.2020.112316]

Source